Retraction to: Effect of progestins with different glucocorticoid activity on bone metabolism (Clinical Endocrinology, 0, 0, (071031031324005-???), 10.1111/j.1365-2265.2007.03059.x);Effect of progestins with different glucocorticoid activity on bone metabolism

Clinical Endocrinology

Volumn 68, Issue 3, 2008, Pages 423-428

  Ishida, Yoichiro ^a   Mine, Takatomo ^a   Taguchi, Toshihiko ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; OSTEOCALCIN; PREMPAK;

ADULT; AGED; ARTICLE; BLEEDING; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; FRACTURE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; X RAY;

EID: 39149120605     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.14291     Document Type: Erratum

References (36)

1. Ravn, S.H., Rosenberg, J. Bostofte, E. (1994) Postmenopausal hormone replacement therapy - clinical implications. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 53, 81 93.
2. Slemenda, S., Hui, S.L., Longcope, C. Johnston, C.C. (1987) Sex steroids and bone mass: a study of changes about the time of menopause. Journal of Clinical Investigation, 80, 1261 1269.
3. Christiansen, C. Riis, B.J. (1990) 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. Journal of Clinical Endocrinology and Metabolism, 71, 836 841.
4. Gallagher, J.C., Kable, W.T. Goldgar, D. (1991) Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. American Journal of Medicine, 90, 171 178.
5. Grey, A., Cundy, T., Evans, M. Reid, I. (1996) Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women. Clinical Endocrinology, 44, 293 296.
6. Ishida, Y. Kawai, S. (2004) Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis. The Yamaguchi Osteoporosis Prevention Study. American Journal of Medicine, 117, 549 555.
7. Speroff, L., Rowan, J., Symons, J., Genant, H. Wilborn, W. (1996) The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study): a randomized controlled trial. Journal of the American Medical Association, 276, 1397 1403.
8. The Writing Group for the PEPI (1996) Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. Journal of the American Medical Association, 276, 1389 1396.
9. Ishida, Y. Heersche, J.N. (2002) Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: an hypothesis. Osteoporosis International, 13, 601 605.
10. Cundy, T., Evans, M., Roberts, H., Wattie, D., Ames, R. Reid, I.R. (1991) Bone density in women receiving depot medroxyprogesterone acetate for contraception. British Medical Journal, 303, 13 16.
11. Cundy, T., Cornish, J., Evans, M.C., Roberts, H. Reid, I.R. (1994) Recovery of bone density in women who stop using medroxyprogesterone acetate. British Medical Journal, 308, 247 248.
12. Mark, S. (1994) Premenopausal bone loss and depot medroxyprogesterone acetate administration. International Journal of Gynecology and Obstetrics, 47, 269 272.
13. Cromer, B.A., Blair, J.M., Mahan, J.D., Zibners, L. Naumovski, Z. (1996) A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. Journal of Pediatrics, 129, 671 676.
14. Ishida, Y. Heersche, J.N.M. (1998) Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological attenuate osteoblast differentiation. Journal of Bone and Mineral Research, 13, 1822 1826.
15. Orimo, H., Sugioka, Y., Fukunaga, M., Muto, Y., Hotokebuchi, T., Gorai, I., Nakamura, T., Kushida, K., Tanaka, H., Ikai, T. Oh-hashi, Y. (1998) Diagnostic criteria of primary osteoporosis. Journal of Bone and Mineral Metabolism, 16, 139 150.
16. Pocock, S.J. Simon, R. (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31, 103 115.
17. Taber, B.Z. (1966) A pharmacologic comparison of norethindrone and chlormadinone acetate. International Journal of Fertility, 11, 287 290.
18. Macdonald, R.R. (1971) Clinical pharmacology of progestogens. In : R.R. Macdonald ed. Scientific Basis of Obstetrics and Gynaecology. Churchill, London, 347 383.
19. Genant, H.K., Wu, C.Y., van Kuijk, C. Nevitt, M.C. (1993) Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research, 8, 1137 1148.
20. Barengolts, E.I., Gajardo, H.F., Rosol, T.J., D'Anza, J.J., Pena, M., Botsis, J. Kukreja, S.C. (1990) Effects of progesterone on postovariectomy bone loss in aged rats. Journal of Bone and Mineral Research, 5, 1143 1147.
21. Tremollieres, F.A., Strong, D.D., Baylink, D.J. Mohan, S. (1992) Progesterone and promegesterone stimulate human bone cell proliferation and insulin-like growth factor-2 production. Acta Endocrinologica, 126, 329 337.
22. Combs, D.W., Reese, K., Cornelius, L.A., Gunnet, J.W., Cryan, E.V., Granger, K.S., Jordan, J.J. Demarest, K.T. (1995) Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors. Journal of Medicinal Chemistry, 38, 4880 4884.
23. Ishida, Y. Heersche, J.N.M. (1999) Progesterone- and dexamethasone- dependent osteoprogenitors in bone cell populations derived from rat vertebrae are different and distinct. Endocrinology, 140, 3210 3218.
24. MacNamara, P. Loughrey, H.C. (1998) Progesterone receptor A and B isoform expression in human osteoblasts. Calcified Tissue International, 63, 39 46.
25. Scheven, B.A.A., Damen, C.A., Hamilton, N.J., Verhaar, H.J.J. Duursma, S.A. (1992) Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochemical and Biophysical Research Communications, 186, 54 60.
26. Slootweg, M.C., Ederveen, A.G.H., Schot, L.P.C., Schoonen, W.G.E.J. Kloosterboer, H.J. (1992) Oestrogen and progestogen synergistically stimulate human and rat osteoblast proliferation. Journal of Endocrinology, 133, R5 R8.
27. Wei, L.L., Leach, M.W., Miner, R.S. Demers, L.M. (1993) Evidence for progesterone receptors in human osteoblast-like cells. Biochemical and Biophysical Research Communications, 195, 525 532.
28. Kontula, K., Paavonen, T., Luukkainen, T. Andersson, L.C. (1983) Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochemical Pharmacology, 32, 1511 1518.
29. Selman, P.J., Wolfswinkel, J. Mol, J.A. (1996) Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids, 61, 133 137.
30. Gram, J., Junker, P., Nielsen, H.K. Bollerslev, J. (1998) Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. Bone, 23, 297 302.
31. Ton, F.N., Gunawardene, S.C., Lee, H. Neer, R.M. (2005) Effects of low-dose prednisone on bone metabolism. Journal of Bone and Mineral Research, 20, 464 470.
32. Prummel, M.F., Wiersinga, W.M., Lips, P., Sanders, G.T. Sauerwein, H.P. (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. Journal of Clinical Endocrinology and Metabolism, 72, 382 386.
33. Struijs, A., Smals, A., de Witte, S.A., Hackeng, W.H. Mulder, H. (2000) Acute effects of etidronate on glucocorticoid-induced bone degradation. Rheumatology, 39, 523 529.
34. Broulík, P.D., Broulíková, K. Necas, E. (2006) Progestagens androgenic action on the bone of male castrated mice. Prague Medical Report, 107, 401 408.
35. Onobrakpeya, O.A., Fall, P.M., Willard, A., Chakravarthi, P., Hansen, A. Raisz, L.G. (2001) Effect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women. Endocrine Research, 27, 473 480.
36. Enríquez, J., Lemus, A.E., Chimal-Monroy, J., Arzate, H., García, G.A., Herrero, B., Larrea, F. Pérez-Palacios, G. (2007) The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites. Journal of Endocrinology, 193, 493 504.